← Leaderboards
David B. Badesch
University Of Colorado Denver
$663,277
Attributed
$663,277
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $20.5K · FY2005–08$25K$18.8K$12.5K$6.3K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$663,277 · 7
By mechanism
K24$616,850 · 1
M01$46,427 · 6
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Raphael A. Nemenoff$15,000,654
- Paul A Bunn$21,859,370
- Mark W Geraci$20,364,365
- Kerrie Moreau$13,944,323
- Rubin M Tuder$19,596,454
Others in their field
Top investigators on “Pulmonary Hypertension”
- Marlene Rabinovitch · Stanford University$37,720,523
- Steven M Kawut · Columbia University Health Sciences$25,789,592
- Jason X.-J. Yuan · University Of California, San Diego$23,628,934
- Serpil C. Erzurum · Cleveland Clinic Lerner Com-Cwru$23,127,355
- Mark Thomas Gladwin · Clinical Center$18,849,194
- Steven Herbert Abman · Johns Hopkins University$18,508,025
Research focus
Pulmonary HypertensionArginineDiet TherapyDietary AminoacidNutrition Related TagHuman SubjectClinical ResearchHuman Therapy EvaluationDietary SupplementsCardiovascular PharmacologyCardiovascular FunctionAntioxidantsProstacyclinsNitric OxideCardiovascular Disorder ChemotherapyVasomotionNitric Oxide SynthaseEnzyme MechanismComputer Retrieval Of Information On Scientific Projects DatabaseGrantPilot ProjectsFundingInstitutionPulmonary Arterial Hypertension
Grant awards (12)
DEPRESSIVE SYMPTOMS IN PULMONARY ARTERIAL HYPERTENSION: PILOT STUDY TO DETERM$2,136
M01 · FY2008 · RR · contact PI
STDY OF SIROLIMUS/RAPAMYCIN IN PTS W/ADVNCD PAH REFRACTORY TO CRNTLY AVAIL THRPY$277
M01 · FY2008 · RR · contact PI
DEPRESSIVE SYMPTOMS IN PULMONARY ARTERIAL HYPERTENSION: PILOT STUDY TO DETERM$18,177
M01 · FY2007 · RR · contact PI
STDY OF SIROLIMUS/RAPAMYCIN IN PTS W/ADVNCD PAH REFRACTORY TO CRNTLY AVAIL THRPY$2,356
M01 · FY2007 · RR · contact PI
RELATIVE ARGININE DEFICIENCY IN PULMONARY HYPERTENSION: PLT STDY-SUPPLEMENTATION$628
M01 · FY2006 · RR · contact PI
RELATIVE ARGININE DEFICIENCY IN PULMONARY HYPERTENSION: PLT STDY-SUPPLEMENTATION$11,152
M01 · FY2005 · RR
RELATIVE ARGININE DEFICIENCY IN PULMONARY HYPERTENSION$122,378
K24 · FY2004 · HL
Relative Arginine Deficiency in Pulmonary Hypertension$11,701
M01 · FY2004 · RR
RELATIVE ARGININE DEFICIENCY IN PULMONARY HYPERTENSION$124,883
K24 · FY2003 · HL
RELATIVE ARGININE DEFICIENCY IN PULMONARY HYPERTENSION$124,023
K24 · FY2002 · HL
RELATIVE ARGININE DEFICIENCY IN PULMONARY HYPERTENSION$123,188
K24 · FY2001 · HL
RELATIVE ARGININE DEFICIENCY IN PULMONARY HYPERTENSION$122,378
K24 · FY2000 · HL